1. Introduction {#s0005}
===============

Negative symptoms of schizophrenia have long been described ([@bb0065]; [@bb0185]; [@bb0215]) and are thought of as being fundamental to the illness ([@bb0065]; [@bb0340]). They occur early in the illness, including in the prodromal phase preceding a first episode of psychosis ([@bb0305]). Negative symptoms are generally not responsive to antipsychotic medication ([@bb0015]; [@bb0250]) and are associated with poor functional outcome ([@bb0225]; [@bb0410]). Although they are correlated with neurocognitive impairments ([@bb0245]), their neurobiological basis remains unknown ([@bb0140]) and may be multifactorial and dependent on their nature (e.g., diminished expression versus amotivation) and chronicity ([@bb0240]).

Prominent negative symptoms are a central feature of the Deficit Syndrome in schizophrenia. This syndrome, first described by Carpenter and colleagues in 1988 ([@bb0080]) requires the presence of primary negative symptoms (i.e. not secondary to factors such as depression, positive symptoms or extrapyramidal features) that endure for least 12 months in the context of a diagnosis of schizophrenia. While Deficit Syndrome is a valid and useful concept, it is difficult to apply in early psychosis populations due to its requirement for a schizophrenia diagnosis and 12-month time frame.

Recently, the concept of Persistent Negative Symptoms (PNS) has been defined and acknowledged as a legitimate treatment target ([@bb0070]). According to the National Institute of Mental Health-MATRICS consensus report, PNS criteria require the presence of prominent negative symptoms of at least moderate severity that have not responded to the usual treatments, cause functional impairment, are present during periods of clinical stability and persist for at least six months ([@bb0070]; [@bb0210]). The most frequent and measurable causes of secondary negative symptoms (positive, depressive and extrapyramidal symptoms) should be absent or at a low level ([@bb0070]; [@bb0255]). Thus PNS is a useful construct in early psychosis due to its shorter time frame and absence of the requirement for a schizophrenia diagnosis ([@bb0135]).

The prevalence of PNS in first episode psychosis samples ranges from about 7% to 31%, depending on the exact PNS criteria used, length of follow up and proportion of individuals with schizophrenia included in the sample. PNS are associated with poor functional outcome in first episode psychosis ([@bb0135]) and with poor premorbid adjustment, especially in the social domain ([@bb0085]; [@bb0355]).

An association between PNS and both male gender ([@bb0085]) and long duration of untreated psychosis ([@bb0235]) has been described in first episode samples. They are more common in first episode patients with early as opposed to adult onset of illness ([@bb0310]). PNS have also been found to be associated with neurocognitive impairments in first episode psychosis, although findings are inconsistent across studies. One study found an association with verbal memory only ([@bb0180]), another with processing speed only ([@bb0095]), while others have shown deficits in executive function ([@bb0310]; [@bb0355]) and attention ([@bb0355]). [@bb0310] also found deficits in global cognition, executive functions, and verbal memory in individuals with PNS with onset of illness before age 17 compared to their counterparts with PNS but with later onset of psychosis. Taken together, these findings are consistent with PNS in early psychosis being conceptually similar to the Deficit Syndrome in schizophrenia, and suggest that PNS may be a manifestation of a neurodevelopmental process.

As PNS are evident early in the course of psychotic disorder, we aimed to determine if they could be detected even before the first psychotic episode, in individuals at Ultra High Risk (UHR) for psychosis. We hypothesised that PNS: i) could be identified in the UHR group; ii) would be associated with features typically described as 'neurodevelopmental risk factors' for schizophrenia: male gender, long duration of illness, poor premorbid adjustment and neurocognitive abnormalities ([@bb0260]; [@bb0375]); and that conversely PNS would not be associated with the 'psychological risk factor' ([@bb0045]; [@bb0220]) of childhood maltreatment. We further hypothesised that iii) PNS would be associated with transition to psychosis; and iv) PNS would be associated with other long-term poor outcomes at follow up such as poor functioning, low quality of life and neurocognitive dysfunction.

2. Method {#s0010}
=========

2.1. Setting and patients {#s0015}
-------------------------

The PACE (Personal Assessment and Clinical Evaluation) Clinic is a specialist clinic for young people at UHR for psychosis located in Melbourne, Australia. The current data are part of a longitudinal study that aimed to reassess all individuals who took part in research at PACE between 1993 and 2006 (*N* = 416). At baseline, patients were aged 15 to 30 years and met UHR criteria rated on the Comprehensive Assessment of At-Risk Mental States (CAARMS) ([@bb0400]). Exclusion criteria were a previous psychotic episode (treated or untreated), organic cause for presentation or past anti-psychotic exposure equivalent to a total haloperidol dose of \>50 mg. The operationalized criteria have previously been described ([@bb0390]; [@bb0395]).

A previously developed tracking system was used to relocate patients ([@bb0170]). The study was approved by the local Research and Ethics Committee. All patients provided written informed consent. Follow-up interviews took place between 2007 and 2009. Three hundred and sixty-three individuals had sufficient data at both baseline and follow up to enable the PNS definition to be applied. For a full description of the sample, see [@bb0285].

2.2. Assessments {#s0020}
----------------

In addition to the CAARMS ([@bb0400]), the following clinical measures were used:

Negative symptoms were assessed with the Schedule for Assessment of Negative Symptoms (SANS) ([@bb0025]) and general psychopathology was assessed using the Brief Psychiatric Rating Scale (BPRS) ([@bb0295]) at baseline and follow up. Premorbid functioning was measured with the Premorbid Adjustment Scale (PAS) ([@bb0075])(higher scores indicate lower functioning) at baseline. As in previous studies ([@bb0020]; [@bb0095]) premorbid adjustment was sub-divided into social and academic functional domains. Functioning and quality of life at follow up were assessed with the Social and Occupational Functioning Assessment Scale (SOFAS) ([@bb0155]) and Quality of Life Scale (QLS) ([@bb0165]) respectively.

Neurocognitive assessments were performed at baseline and follow up. Memory was assessed by Logical memory I and Visual Reproduction I from the Wechsler Memory Scale-Revised. The Verbal Memory Index was calculated from Logical memory I and Verbal Paired Associates I. The Trail Making Test Parts A and B ([@bb0320]) were used. Trails A indexes psychomotor speed, while Trails B measures set-shifting. The total words generated from the letters F, A, and S on the COWAT ([@bb0050]) provided a measure of verbal fluency at baseline only.

History of childhood maltreatment was assessed using the brief Childhood Trauma Questionnaire (CTQ) ([@bb0055]), a 28-item self-report instrument that assesses childhood experiences of physical abuse and neglect, sexual abuse and emotional abuse and neglect and provides a total score for all trauma.

2.3. Definition of persistent negative symptoms {#s0025}
-----------------------------------------------

Consistent with the Buchanan criteria ([@bb0070]), PNS were defined as presence of at least one SANS global subscale score ≥3 at baseline and at follow up, a combined total score of 6 or less on the BPRS subscales of depression, guilt and suicidality (corresponding to an average of "very mild" or less on each item), and a combined total score of 16 or less on the BPRS psychotic subscales of conceptual disorganisation, hallucinations, suspiciousness and unusual thought content (corresponding to an average of "moderate" or less on each item). No measure of extrapyramidal symptoms was used. However, UHR individuals in the study group were not treated with antipsychotic medication at baseline.

2.4. Analyses {#s0030}
-------------

We compared those with PNS ("PNS") and those without PNS ("noPNS"). Categorical variables were compared using chi-squared tests. Continuous independent variables were checked for normality using visual inspection of the histograms and Q-Q plots and Kolmogorov-Smirnov test with Lilliefors correction ([@bb0300]). Skewed variables were log-transformed. Independent *t*-tests were then used to compare means. An alpha level of 0.05 was used for all statistical tests, with the Benjamini & Hochberg False Discovery Rate (B-H FDR) used to correct for multiple comparisons ([@bb0035]; [@bb0040]). B-H FDR was chosen as, unlike the Bonferroni procedure, it does not assume that all tests are independent. (In this case, for example, SOFAS and QLS are highly correlated, and Trails A and Trails B are highly correlated with each other at baseline and follow up).

3. Results {#s0035}
==========

Three hundred and sixty-three participants had data at both baseline and follow up that enabled the above definition of PNS to be applied. Mean follow up time was 7.4 years for the noPNS group and 7.8 years for the PNS group (*t* = −0.524, *p* = 0.601). Of the 363 participants, 22 (6.1%) had PNS and 341 (93.9%) did not. Mean age did not differ between the groups (baseline mean age noPNS = 18.7, SD 3.3; PNS = 18.7, SD 3.1). Proportion of males in each group did not differ significantly (PNS: 54.5% male, noPNS: 42.2%, *χ*^2^ (1) = 1.251, *p* = 0.263, adjusted *p* = 0.4653).

3.1. Premorbid and baseline correlates of PNS {#s0040}
---------------------------------------------

Duration of illness prior to presentation to the PACE Clinic (variable log-transformed) was longer in the PNS group compared to the noPNS group, but not significantly after adjusting for multiple comparisons (see [Table 1](#t0005){ref-type="table"}). Premorbid social adjustment was significantly worse in the PNS group compared to the noPNS group. This was evident across the premorbid developmental periods of early adolescence (aged 12--15) and late adolescence (aged 16--18). Although there was no significant difference in childhood social functioning, the effect size of premorbid social adjustment differences between the PNS and noPNS groups was consistently large across the developmental ages from childhood to late adolescence (see [Table 1](#t0005){ref-type="table"}). The only significant difference between the groups in academic adjustment was in late adolescence, with no differences in childhood or early adolescence.Table 1Baseline associations for individuals with and without PNS.Table 1PNSn^a^No PNSn^b^M (95% CI)M (95% CI)tAdjusted pCohen\'s dDuration of illness, days^c^384.8 (203.8; 726.4)17206.3 (174.5; 242.5)228−2.0010.1060.51CTQ total^c^55.47 (46.44; 66.24)2043.91 (41.08; 46.12)208−2.4680.0400.65PNSn^a^No PNSn^b^M (SD)M (SD)tAdjusted pCohen\'s dPAS childhood -social2.75 (1.67)81.45 (1.42)70−2.1230.0950.84PAS childhood - academic1.75 (1.29)81.52 (1.14)70−0.4680.8190.19PAS early adolescence -- social3.05 (1.39)81.74 (1.36)70−2.5050.0460.95PAS early adolescence -- academic2.17 (1.60)82.13 (1.50)70−0.0510.9990.03PAS late adolescence -- social3.39 (2.33)71.74 (1.32)55−2.6700.0460.87PAS late adolescence -- academic3.38 (1.80)71.60 (1.19)55−2.7710.0461.09Logical memory^d^−0.172 (0.98)40.010 (1.00)680.3530.8780.18Visual reproduction^d^−0.195 (1.09)40.034 (1.00)680.9360.5370.22Verbal memory index^d^−0.029 (1.07)40.005 (1.00)680.0370.9710.03Verbal fluency^d^−1.188 (0.369)40.069 (0.982)682.5360.0491.32Trails A time(seconds)50.00 (45.07)427.65 (8.84)68−0.9900.5340.69Trails B time(seconds)119.00 (45.07)475.69 (33.96)68−1.0830.5121.09[^1]

Baseline verbal fluency (COWAT score) was significantly poorer in the PNS group compared to the noPNS group. There were no differences between the groups in Trails A, Trails B, Logical Memory, Visual Reproduction or Verbal Memory Index at baseline (see [Table 1](#t0005){ref-type="table"}). The number of participants with baseline neurocognitive data was small and insufficient to analyse the transitioned and non-transitioned groups separately. It was not possible to conduct a logistic regression to examine predictors due to the large amount of missing data. Very few UHR individuals had both PAS and neurocognitive data available.

Participants in the PNS group had a significantly higher CTQ score (log transformed) compared to those without PNS ([Table 1](#t0005){ref-type="table"}). Post-hoc testing to examine the sub-type of childhood maltreatment revealed that the higher CTQ scores in the PNS group were due to higher emotional neglect in this group compared to the noPNS group. There were no differences between the groups in the other CTQ subscales (see [Table 2](#t0010){ref-type="table"}).Table 2Post-hoc comparison of subtypes of childhood maltreatment in individuals with and without PNS.Table 2PNS\
*N* = 228No PNS\
*N* = 17t*p*Cohen\'s dCTQ emotional abuse[a](#tf0005){ref-type="table-fn"}12.81 (1.54)10.49 (1.62)−1.7500.0820.44CTQ emotional neglect[a](#tf0005){ref-type="table-fn"}15.09 (1.50)10.57 (1.58)−3.2960.0010.83CTQ physical abuse[a](#tf0005){ref-type="table-fn"}9.17 (1.81)7.44 (1.57)−1.4930.1510.38CTQ physical neglect[a](#tf0005){ref-type="table-fn"}8.53 (1.51)7.26 (1.43)−1.5020.1340.38CTQ sexual abuse[a](#tf0005){ref-type="table-fn"}7.01 (1.76)6.40 (1.62)−0.7760.4380.20[^2][^3]

3.2. Outcomes of participants with PNS compared to those without PNS {#s0045}
--------------------------------------------------------------------

Ten of the 22 participants in the PNS group developed psychosis (42.9%) compared to 89 of 341 in the noPNS group (26.3%), a non-significant difference after adjusting for multiple comparisons (*χ*^2^ (1) = 3.903, unadjusted *p* = 0.046, adjusted *p* = 0.0962).

PNS were associated with poor psychosocial functioning at follow-up, with mean SOFAS and QLS scores both significantly different between the groups with large effects sizes (see [Table 3](#t0015){ref-type="table"}). In post-hoc testing to compare participants that transitioned to psychosis and those that did not, functioning and quality of life at follow up was significantly worse in those with PNS compared to those without PNS in both transitioned and non-transitioned groups ([Table 4](#t0020){ref-type="table"}).Table 3Outcomes at long-term follow-up for individuals with and without PNS.Table 3PNS\
*N* = 22No PNS\
*N* = 245*t*Adjusted pCohen\'s dM (SD)M (SD)SOFAS48.32 (11.02)69.35\
(15.50)6.221\<0.0011.56QLS61.36 (20.73)99.72 (22.27)8.44\<0.0011.78Logical memory[a](#tf0010){ref-type="table-fn"}, [b](#tf0015){ref-type="table-fn"}0.04 (1.01)0.02 (1.00)−0.1910.9760.02Visual reproduction[a](#tf0010){ref-type="table-fn"}, [b](#tf0015){ref-type="table-fn"}−0.20 (1.09)0.02 (0.98)0.9460.5750.21Verbal memory index[a](#tf0010){ref-type="table-fn"}, [b](#tf0015){ref-type="table-fn"}−0.02 (0.66)0.01 (1.00)0.2520.9670.04Trails A time (seconds)[b](#tf0015){ref-type="table-fn"}36.40 (11.03)28.37 (12.10)−2.8670.0380.69Trails B time (seconds)[b](#tf0015){ref-type="table-fn"}73.74 (24.86)64.37 (21.22)−1.8250.1320.41[^4][^5][^6][^7]Table 4Post-hoc comparison of outcomes for individuals with and without PNS in the group that transitioned and the group that did not transition.Table 4No transition to psychosisTransition to psychosisPNS\
*N* = 11No PNS\
*N* = 177t*p*PNS\
*N* = 9No PNS\
*N* = 57t*p*M (SD)M (SD)SOFAS51.00 (10.85)72.14 (13.23)5.410\<0.00145.10 (10.89)61.35 (18.58)2.683\<0.001QLS55.83 (19.70)103.63 (17.61)9.037\<0.00168.00 (20.94)88.49 (29.48)2.1090.038Logical memory[a](#tf0020){ref-type="table-fn"}, [b](#tf0025){ref-type="table-fn"}0.148 (0.83)0.071 (1.00)−0.2520.801−0.076 (1.24)−0.210 (1.06)−0.3570.722Visual reproduction[a](#tf0020){ref-type="table-fn"}, [b](#tf0025){ref-type="table-fn"}−0.256 (1.07)0.108 (0.90)1.2830.201−0.121 (1.74)−0.248 (1.74)−0.3000.765Verbal memory index[a](#tf0020){ref-type="table-fn"}, [b](#tf0025){ref-type="table-fn"}0.205 (0.68)0.071 (0.97)−0.4490.654−0.316 (1.41)−0.199 (1.06)0.2920.771Trails A time (seconds)[b](#tf0025){ref-type="table-fn"}33.64 (6.19)27.94 (12.50)−4.1970.13639.78 (14.76)29.70 (10.75)−2.4790.016Trails B time (seconds)[b](#tf0025){ref-type="table-fn"}67.10 (12.83)62.79 (20.27)9.490.50881.11 (33.00)69.21 (23.43)−1.2870.203[^8][^9][^10][^11]

Processing speed (Trails A) at follow up was significantly slower in the PNS group compared to the noPNS group. Logical Memory, Visual Memory and Verbal Memory Index and Trails B did not differ significantly between the groups. In those who transitioned to psychosis, Trails A was also significantly slower at follow up in the PNS group compared to the noPNS group. There were no other differences in neurocognitive functioning between the PNS and noPNS in those who transitioned to psychosis. There were no significant differences in neurocognitive performance at follow up between the PNS and noPNS groups in those who did not transition to psychosis (see [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}).

4. Discussion {#s0050}
=============

4.1. Summary of findings {#s0055}
------------------------

In this study, we showed that PNS begin even before the onset of the first psychotic episode, in the group at UHR for psychosis, with a prevalence of 6.1%. This is lower than rates found in first episode samples. This is to be expected, as not all UHR patients will develop a psychotic disorder and some may never have been truly at risk ([@bb0385]).

We found that individuals with PNS showed poor premorbid adjustment. This is consistent with evidence showing that people with schizophrenia frequently have poor premorbid adjustment before illness onset (e.g. see ([@bb0330]) for a review) and that poor premorbid adjustment is associated with negative symptoms and poor outcome, including in first episode psychosis samples ([@bb0095]; [@bb0195]; [@bb0205]). Our PNS group had poor premorbid social but not academic functioning compared to the noPNS group. This is consistent with studies in first episode psychosis ([@bb0095]; [@bb0090]; [@bb0195]), and with the finding that poor social functioning is more stable than poor role functioning in the UHR group ([@bb0110]). The finding of reduced academic as well as social functioning in late adolescence may reflect that the UHR state was already manifest.

Of note is that the large effect size for all social PAS scores was consistent across childhood, early adolescence and late adolescence, implying chronic social impairment from an early age, consistent with a neurodevelopmental disorder. The finding of a baseline neurocognitive decrement in verbal fluency further supports this hypothesis. Against this hypothesis was the finding of no association between PNS and male gender or with long duration of illness, and that only one domain of neurocognitive function was lower in the PNS group. It is also possible that negative symptoms may influence premorbid adjustment, especially if negative symptoms have an early onset. However, we were unable to investigate the direction of causality in this study as premorbid adjustment and baseline negative symptoms were both assessed at study entry.

Further, while childhood trauma is a risk factor for psychotic illnesses including schizophrenia ([@bb0360]), we hypothesised that there would be no difference in rates of this between the PNS and noPNS groups. This was based on speculation that there are two pathways to developing schizophrenia, "neurodevelopmental" ([@bb0260]; [@bb0375]) and "psychological" ([@bb0045]; [@bb0220]), with PNS being a manifestation of the 'neurodevelopmental' pathway. However, we found higher rates of childhood maltreatment in the PNS group compared to the noPNS group. Thus dividing psychotic disorders into "neurodevelopmental" and "psychological" may be a false dichotomy. Indeed, recent thinking around the neurodevelopmental hypothesis of schizophrenia posits that genetic liability, early adverse experiences (including childhood abuse) and later stressors interact in a "Developmental Risk Factor Model of Psychosis" ([@bb0265]). Childhood trauma may act as a risk factor through several different mechanisms. It is thought to sensitise vulnerable individuals to stress possibly through alterations in the hypothalamic-pituitary-adrenal (HPA) axis ([@bb0100]; [@bb0220]). Psychological reactions to history of abuse, such as enhanced threat anticipation, external attributional biases and heightened interpersonal sensitivity, can create increased stress and a vicious cycle ([@bb0315]). Further, the detrimental effects of childhood maltreatment on the developing brain may contribute to the cognitive impairments found in psychotic disorders ([@bb0005]; [@bb0335]). Recently it has been suggested that childhood trauma increases proneness to psychosis through its effect on self-disturbances (anomalies in the subjective experience of the self) ([@bb0145]).

However, while there is increasing evidence about potential mechanisms by which childhood trauma increases risk of positive symptoms and cognitive dysfunction in psychotic disorders, there is a paucity of research linking childhood abuse and negative symptoms. The current study found higher rates of childhood emotional neglect, but not other forms of abuse, in the PNS group compared to the noPNS group. We could speculate that children with delayed development and unusual affect may be susceptible to this form of maltreatment, or that emotional neglect may contribute to a withdrawn, isolative state characteristic of negative symptoms. It may also be that parents with schizophrenia may be prone to emotionally neglect their children, so an underlying genetic cause and/or a gene-environment interaction may be occurring, such that the parent with negative symptoms may emotionally neglect a child who is genetically vulnerable to negative symptoms and the neglect also results in negative symptoms. This is all speculative, and further research in the area of childhood trauma and negative symptoms is needed.

As hypothesised, compared to participants without PNS, those with PNS had poorer long-term social functioning and quality of life. This was evident in both the group that did and did not develop psychosis. These results are consistent with findings in first episode psychosis populations showing that PNS predict poor functional outcome ([@bb0095]; [@bb0135]; [@bb0175]; [@bb0205]; [@bb0365]).

Verbal memory, verbal fluency and processing speed have previously been found to be associated with negative symptoms and functional disability in schizophrenia ([@bb0245]; [@bb0270]; [@bb0290]). While we did not find any memory dysfunction in this UHR PNS group compared to the noPNS group, our study showed that the PNS group had impaired verbal fluency at baseline and slowed processing speed at follow up, including in the subsample that developed psychosis. Previous research has suggested that processing speed is a core factor determining functional capacity in schizophrenia and mediates the relationship between verbal memory, verbal fluency and functioning ([@bb0290]), while others suggest that negative symptoms explain most of the variance in functioning ([@bb0120]; [@bb0325]) and influence the ability to process information. More recently it has been suggested that premorbid adjustment and verbal memory contribute to functional outcomes in first episode psychosis through both persistent positive and negative symptoms. In this model, while PNS have a greater and more prolonged effect on functioning, persistent positive symptoms significantly reduce functioning early in the course of illness ([@bb0205]). We were not able to examine these associations in our study, but our findings indicate that functional disability, slower processing speed, and negative symptoms occur early in the course of illness. Individuals with these features may be at risk of non-recovery.

Half of the patients with PNS in this sample did not develop a psychotic disorder at follow up. Nonetheless they were functioning poorly. It may be that PNS are a marker of poor functional outcome, regardless of diagnosis. The PNS group that did not transition could be conceptualised as having negative schizotypy - schizotypal personality disorder without positive symptoms - or schizotaxia - a non-psychotic condition on the schizophrenia spectrum characterised by negative symptoms and neurocognitive impairment ([@bb0350]). Their presentation is also consistent with Cornblatt et al.\'s "CASIS" syndrome, a constellation of cognitive deficits, affective disturbances, social isolation, neurocognitive impairment and school failure, that they view as an early "prodrome" to schizophrenia, occurring before the onset of positive psychotic experiences ([@bb0105]). All of these constructs are conceptually similar. It may be that presence of PNS indicates a subtype of UHR patients who are closer to the neurodevelopmental type of schizophrenia than those without PNS, even in the absence of development of full threshold positive psychotic symptoms. The clinical picture may remain stable and these individuals may continue to function poorly even in the absence of transition to psychosis ([@bb0405]). Additionally, some of these individuals may continue to be at risk of developing a psychotic disorder.

4.2. Clinical implications {#s0060}
--------------------------

Our study has potential clinical implications. Currently individuals meeting UHR criteria are offered cognitive behavioural therapy and monitoring of mental state, regardless of presentation ([@bb0275], [@bb0280]). Finding that PNS begin and are identifiable in the UHR group means that it may be possible to stratify UHR patients and target the PNS group for specific treatment, such as exercise ([@bb0125]; [@bb0130]), cognitive remediation ([@bb0030]; [@bb0190]), and other psychosocial treatments ([@bb0230]), and for development and trialling of new interventions ([@bb0115]; [@bb0150]; [@bb0190]). It also means that first episode psychosis patients should have their negative symptoms carefully assessed, as PNS may be identifiable in these individuals soon after service entry if they had a history of primary negative symptoms in the prodromal period or even prior to this. This suggests the possibility for early stratification of care pathways for these patients as well. The above treatments could be used along with early consideration of clozapine therapy -- currently underused in early psychosis ([@bb0345]).

4.3. Limitations {#s0065}
----------------

PNS in this UHR study group were defined as presence of negative symptoms at baseline and follow up. The follow up period varied between 2.4 and 14.9 years. Although all had negative symptoms for at least 6 months, as specified in Buchanan\'s definition ([@bb0070]), the duration varied. Additionally, we do not know if there was any period of remission of negative symptoms between follow up points. To exclude secondary negative symptoms due to depression, we used the BPRS subscales of depression, guilt and suicidality but not anxiety. The rationale for this was that recent research applying the polygenic risk score for schizophrenia to a community sample of young people suggests that genetic risk for schizophrenia manifests itself in adolescence as negative symptoms and anxiety but not depression ([@bb0200]). Thus including anxiety may mask a genetic vulnerability to schizophrenia. We note also that the Calgary Depression Scale for Schizophrenia ([@bb0010]), which does not include any anxiety items, is recommended by [@bb0070], and was used by [@bb0175], to exclude depressive symptoms from the definition of PNS.

A further limitation was that there were few individuals with PNS, and the number of PNS participants in the post-hoc analysis of transitioned versus non-transitioned samples was small (*n* = 9 and 11 respectively). Missing data was also a problem. Because few participants had neurocognitive, childhood trauma and premorbid adjustment assessments, we were unable to conduct a logistic regression to examine predictors of PNS in more detail to investigate the amount of variance explained by each potential factor. Further, some of the poor functional outcome in the PNS group that developed psychosis could be due to issues other than the PNS, such as positive symptoms, substance abuse and other factors known to impact on functional outcome in early psychosis ([@bb0060]; [@bb0205]; [@bb0370]; [@bb0380]).

4.4. Conclusion {#s0070}
---------------

Our study indicates that PNS are identifiable early in the course of psychotic illness. Negative symptoms should be assessed and monitored in the UHR group. Further research using larger samples would be valuable. This may enable the examination of separate diminished expression and avolition-apathy PNS subtypes and could investigate the pathophysiology of PNS and their association with neurocognition, premorbid adjustment and childhood trauma. This could lead to hypothesis-driven intervention trials in early psychosis directed towards this important unmet therapeutic target.
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[^1]: Abbreviations: PNS = persistent negative symptoms, n^a^ = number with PNS, n^b^ = number with noPNS, PAS = Premorbid Adjustment Scale, CTQ = Childhood Trauma Questionnaire; ^c^natural log back transformed; ^d^reported as z scores.

[^2]: Abbreviations: CTQ = Childhood Trauma Questionnaire.

[^3]: Natural log back transformed.

[^4]: Abbreviations: PNS = persistent negative symptoms; SOFAS = Social and Occupational Functioning Assessment Scale; QLS = Quality of Life Scale.

[^5]: noPNS = 234, PNS = 20.

[^6]: Reported as z-score.

[^7]: Numbers for neurocognitive testing.

[^8]: Abbreviations: PNS = persistent negative symptoms; SOFAS = Social and Occupational Functioning Assessment Scale; QLS = Quality of Life Scale.

[^9]: noPNS = 234, PNS = 20.

[^10]: Reported as z-score.

[^11]: Numbers for neurocognitive testing.
